Aignostics
aignostics.com
Actively hiring
Foundation Models
Precision Medicine
Medical AI
As featured in
View 1 job
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$34M
1 round on record
Latest round
$34M
Series B · Nov 2024 · 22 mo ago
Team
51-200
employees, estimated range
Hiring now
1
open roles
Backers
1
IBB Ventures
The money's age
Due for its next round
22 months since the last round · hiring slowed
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 12
Launched Aignostics Launches PathoSearch, a Visual Search Engine for Pathology Cases · PRNewswire
Sep 12
Partnership Aignostics Joins Techcyte Fusion Partner Program to Bring PathoSearch to Fusion AP · dispatch.com
Jun 9
Partnership Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research · morningstar.com
Oct 15, 2025
Launched Aignostics Launches AI-Powered Application for Tumor Microenvironment Profiling · YahooFinance
Nov 3, 2024
Raised a round Series B $34M · Pulse 2.0
2018
Founded
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | Nov 2024 | $34M | — | Pulse 2.0 |
Registers and programsofficial lists and records that name the company
| Legal entity | Aignostics GmbH | its site |
Founders and leadersfrom filings, registers and the company's site
Viktor MatyasVertreten durchcompany's site
Backed byfrom the funds' portfolios and accelerator catalogs
IBB Ventures Investors in similar startupsfunds that back the companies most like this one
backs Topological, Vorelios
backs Eupnoos
backs Panakeia
backs Mindpeak
backs Mindpeak
backs DoMore Diagnostics
Similar startupsby what they do, their industry and backers
Panakeia is a London medical technology company founded in 2018 that predicts molecular tumour profiles from routine pathology slides. Its…
DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug…
Optomics® uses photonics and AI to decode human biology for clinical diagnostics, trial stratification, and drug development. Personalized…
Mindpeak transforms tissue into high-dimensional data, enabling the discovery of AI-driven biomarkers that guide targeted therapies and…
Ascléa entwickelt souveräne KI für Krankenhäuser. Aus der Charité – Universitätsmedizin Berlin, ISO 13485 zertifiziert. Foundation Model…
Vorelios is building a foundation model for engineering physics.
Overview
Aignostics is a Berlin company founded in 2018 as a spin-out from the Charité hospital and its artificial intelligence institute. Its pathology foundation models analyse tissue images to support drug development and diagnostics. The company works with pharmaceutical partners on biomarker discovery from digitised slides.
News
Aignostics Launches PathoSearch, a Visual Search Engine for Pathology Cases
Today, Aignostics announced the early access release of PathoSearch, a visual search engine for pathology cases. From a single screenshot of a region of interest on an H&E slide, PathoSearch instantly retrieves morphologically similar, diagnosed reference
Read more
Report
Aignostics Launches PathoSearch, a Visual Search Engine for Pathology Cases
/PRNewswire/ -- Today, Aignostics announced the early access release of PathoSearch, a visual search engine for pathology cases. From a single screenshot of a...
Read more
Report
Aignostics leads latest crop of digital health financings
Our round-up of funding rounds in the digital health arena features Aignostics, TCC, Yazen Health, Nema Health, Alimetry, and Research Grid.
Read more
Report
Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research
Collaboration will apply Aignostics' AI-technology to PanCAN's multimodal pancreatic cancer dataset, with results made broadly accessible to both academic and life sciences researchers.LOS ANGELES
Read more
Report
Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research
Read more
Report
Aignostics Announces New State-of-the-Art Pathology Foundation Model
/PRNewswire/ -- Today, Aignostics announced research results for Atlas 2, an updated version of its pathology foundation model. Built in collaboration with...
Read more
Report
Aignostics Announces New State-of-the-Art Pathology Foundation Model
Atlas 2 sets new industry standard and achieves best-in-class performance and computational efficiencyBERLIN and NEW YORK, Jan. 13, 2026 /PRNewswire/ -- Today, Aignostics announced research
Read more
Report
Aignostics Launches AI-Powered Application for Tumor Microenvironment Profiling
Following successful early access pilots with leading biopharma partners, Aignostics today announced the general availability of Atlas H&E-TME, an application for analyzing the tumor microenvironment (TME) in H&E images. Atlas H&E-TME addresses a critical
Read more
Report
Aignostics: $34 Million (Series B) Raised To Turn Complex Pathology Data Into Transformative Insights
Aignostics - a global AI company that turns complex multi-modal pathology data into transformative insights - announced that it has raised $34 million in Series B financing. This additional funding will be used for building new product offerings for bioph
Read more
Report
Show more news
People
Viktor Matyas
Vertreten durch
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
42/100
Stable
Open positions
1
0 opened / 0 closed in 30 days
Median time-to-fill
120 days
faster than 14% of the market
ATS activity
Every ~2 days
09/29/2026
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Product
100% ▼
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Berlin
Berlin
Germany
HQ
1 open roles 100% remote 50-200 est. staff
hires for Product
Alt-Moabit 73
Jobs
≈ $85k – $162k per year (Estimated) • Remote (likely Germany) • Full-Time • Berlin
Apply
Financials
Total raised
$34M
Latest round
Series B
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series B | 2024 | $34M | Details |